On 5 March, the The American College of Cardiology (ACC) and Elsevier announced the launch of JACC: Heart Failure, a new journal dedicated to meet the demands and challenges of treating what is now the most rapidly increasing category of cardiac disease. The first publication is now available.
Christopher O’Connor has been appointed as editor-in-chief of JACC: Heart Failure. The publication will release bi-monthly issues and will focus on new research and treatment options for heart failure patients.
A state-of-the-condition update by Eugene Braunwald and the breadth of articles featured in the first issue are an example of the journal’s aims to publish the full range of topics related to this condition including basic and translational science, trials and registries, co-morbidities, biomarkers, advanced heart failure, and outcomes.
“The addition of JACC: Heart Failure to ACC’s current portfolio will help meet the need for more research in this growing field,” said William Zoghbi, ACC president. “With the increasing rate of patients suffering from heart failure, the science presented in this new journal will give cardiologists access to valuable new research.”
“We are delighted to be publishing JACC: Heart Failure in collaboration with the ACC,” said Cynthia Baudendistel, executive publisher for the ACC journals at Elsevier. “We look forward to seeing the impact this journal will make on cardiology practice, research, teaching, and advocacy.”
For more information or to submit an article, go to: heartfailure.onlinejacc.org or jaccsubmit-heartfailure.org.
